InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,344.39
(
0.00%
)
US TECH 100
18,066.40
(
0.28%
)
Dow Jones
39,357.01
(
-0.36%
)
Brent Oil
81.41
(
-0.24%
)
Bitcoin
59,165.43
(
-0.32%
)

Replies to post #223542 on Biotech Values

Replies to #223542 on Biotech Values
icon url

DewDiligence

02/09/19 11:42 AM

#223582 RE: DewDiligence #223542

ENTA’s enterprise value at the current share price ($90.63) is approximately $1.5B, based on 22.5M fully-diluted shares (#msg-146710316) and a pro forma cash balance of $412.2M (#msg-146710290).
icon url

DewDiligence

03/18/19 9:42 AM

#224130 RE: DewDiligence #223542

ENTA completes enrollment in phase-2 NASH and RSV trials:

https://www.enanta.com/investors/news-releases/press-release/2019/Enanta-Pharmaceuticals-Completes-Enrollment-in-Two-Ongoing-Phase-2-Studies/default.aspx
icon url

DewDiligence

06/02/19 6:12 PM

#225135 RE: DewDiligence #223542

ENTA’s enterprise value at the current share price ($90.47) is approximately $1.6B, based on 22.6M fully-diluted shares (#msg-149160807) and a pro forma cash balance of $419.8M (#msg-149160802).